Long non-coding RNAs in liver diseases: Focusing on nonalcoholic fatty liver disease, alcohol-related liver disease, and cholestatic liver disease

키워드

참고문헌 (66)

1. ENCODE Project Consortium, "Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project", Nature, 447, pp.799~816 (2007)
2. ENCODE Project Consortium, "An integrated encyclopedia of DNA elements in the human genome", Nature, 489, pp.57~74 (2012)
3. Yamamura S, "Interaction and cross-talk between non-coding RNAs", Cell Mol Life Sci, 75, pp.467~484 (2018)
4. Djebali S, "Landscape of transcription in human cells", Nature, 489, pp.101~108 (2012)
5. Erdmann VA, "Collection of mRNA-like non-coding RNAs", Nucleic Acids Res, 27, pp.192~195 (1999)
6. Danko CG, "Signaling pathways differentially affect RNA polymerase II initiation, pausing, and elongation rate in cells", Mol Cell, 50, pp.212~222 (2013)
7. Johnsson P, "Evolutionary conservation of long non-coding RNAs; sequence, structure, function", Biochim Biophys Acta, 1840, pp.1063~1071 (2014)
8. Novikova IV, "Tackling structures of long noncoding RNAs", Int J Mol Sci, 14, pp.23672~23684 (2013)
9. Yan K, "Structure prediction : new insights into decrypting long noncoding RNAs", Int J Mol Sci, 17, pp.132~ (2016)
10. Jasdeep Kaur Dhanoa, "Long non-coding RNA: its evolutionary relics and biological implications in mammals: a review", 한국축산학회지, 60(10), pp.1~10 (2018), 한국축산학회[DOI]
11. Hermans-Beijnsberger S, "Long non-coding RNAs in the failing heart and vasculature", Noncoding RNA Res, 3, pp.118~130 (2018)
12. Jarroux J, "History, Discovery, and Classification of lncRNAs", Adv Exp Med Biol, 1008, pp.1~46 (2017)
13. Huang B, "Regulatory non-coding RNAs : revolutionizing the RNA world", Mol Biol Rep, 41, pp.3915~3923 (2014)
14. Dykes IM, "Transcriptional and post-transcriptional gene regulation by long non-coding RNA", Genomics Proteomics Bioinformatics, 15, pp.177~186 (2017)
15. Wang KC, "Molecular mechanisms of long noncoding RNAs", Mol Cell, 43, pp.904~914 (2011)
16. Guttman M, "lincRNAs act in the circuitry controlling pluripotency and differentiation", Nature, 477, pp.295~300 (2011)
17. Tsai MC, "Long noncoding RNA as modular scaffold of histone modification complexes", Science, 329, pp.689~693 (2010)
18. Long Y, "How do lncRNAs regulate transcription?", Sci Adv, 3, pp.eaao2110~ (2017)
19. Keniry A, "The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and Igf1r", Nat Cell Biol, 14, pp.659~665 (2012)
20. Yoon JH, "Functional interactions among microRNAs and long noncoding RNAs", Semin Cell Dev Biol, 34, pp.9~14 (2014)
21. Salmena L, "A ceRNA hypothesis : the Rosetta Stone of a hidden RNA language?", Cell, 146, pp.353~358 (2011)
22. Ebert MS, "MicroRNA sponges : progress and possibilities", RNA, 16, pp.2043~2050 (2010)
23. Streba LA, "Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma : an open question", World J Gastroenterol, 21, pp.4103~4110 (2015)
24. Zhao Y, "Long non-coding RNA in liver metabolism and disease : current status", Liver Res, 1, pp.163~167 (2017)
25. Chen G, "LncRNA SRA promotes hepatic steatosis through repressing the expression of adipose triglyceride lipase(ATGL)", Sci Rep, 6, pp.35531~ (2016)
26. Puigserver P, "Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction", Nature, 423, pp.550~555 (2003)
27. Zhu X, "Upregulation of lncRNA MEG3promotes hepatic insulin resistance via increasing FoxO1 expression", Biochem Biophys Res Commun, 469, pp.319~325 (2016)
28. Zhu X, "lncRNA MEG3 promotes hepatic insulin resistance by serving as a competing endogenous RNA of miR-214 to regulate ATF4 expression", Int J Mol Med, 43, pp.345~357 (2019)
29. Zhang M, "Long noncoding RNA lncARSR promotes hepatic lipogenesis via Akt", SREBP-1c pathway and contributes to the pathogenesis of nonalcoholic steatohepatitis, 2018, pp.499, 66~70
30. Huang J, "Long noncoding RNA lncARSR promotes hepatic cholesterol biosynthesis via modulating Akt", SREBP-2, Life Sci, pp.2018, 203[DOI]
31. Atanasovska B, "A liver-specific long noncoding RNA with a role in cell viability is elevated in human nonalcoholic steatohepatitis", Hepatology, 66, pp.794~808 (2017)
32. Wang J, "Long noncoding RNA lncSHGL recruits hnRNPA1 to suppress hepatic gluconeogenesis and lipogenesis", Diabetes, 67, pp.581~593 (2018)
33. Qian K, "The long noncoding RNA NEAT1 interacted with miR-101 modulates breast cancer growth by targeting EZH2", Arch Biochem Biophys, 615, pp.1~9 (2017)
34. Wang X, "Down-regulation of lncRNA-NEAT1 alleviated the nonalcoholic fatty liver disease via mTOR", S6K1 signaling pathway, 2018, pp.119, 1567~1574
35. Yan B, "Aberrant expression of long noncoding RNAs in early diabetic retinopathy", Invest Ophthalmol Vis Sci, 55, pp.941~951 (2014)
36. Puthanveetil P, "Long noncoding RNA MALAT1 regulates hyperglycaemia induced inflammatory process in the endothelial cells", J Cell Mol Med, 19, pp.1418~1425 (2015)
37. Yan C, "Long noncoding RNA MALAT1 promotes hepatic steatosis and insulin resistance by increasing nuclear SREBP-1c protein stability", Sci Rep, 6, pp.22640~ (2016)
38. Leti F, "Altered expression of MALAT1 lncRNA in nonalcoholic steatohepatitis fibrosis regulates CXCL5 in hepatic stellate cells", Transl Res, 190, pp.25~39.e21 (2017)
39. Liu J, "LncRNA-H19 promotes hepatic lipogenesis by directly regulating miR-130a", PPARγ axis in non-alcoholic fatty liver disease, 2019, pp.39, BSR20181722~
40. Wang H, "Long non-coding RNA(lncRNA)H19 induces hepatic steatosis through activating MLXIPL and mTORC1 networks in hepatocytes", J Cell Mol Med, 24, pp.1399~1412 (2020)
41. Liu C, "Long noncoding RNA H19 interacts with polypyrimidine tract-binding protein 1 to reprogram hepatic lipid homeostasis", Hepatology, 67, pp.1768~1783 (2018)
42. Rehm J, "Global burden of alcoholic liver diseases", J Hepatol, 59, pp.160~168 (2013)
43. Liangpunsakul S, "Alcoholic liver disease in Asia, Europe, and North America", Gastroenterology, 150, pp.1786~1797 (2016)
44. Wang Q, "The long non-coding RNA MEG3", miR-let-7c-5p axis regulates ethanol-induced hepatic steatosis and apoptosis by targeting NLRC5, 2018, pp.9, 302~
45. Quinn JJ, "Unique features of long non-coding RNA biogenesis and function", Nat Rev Genet, 17, pp.47~62 (2016)
46. Yang Z, "LncRNA AK054921 and AK128652 are potential serum biomarkers and predictors of patient survival with alcoholic cirrhosis", Hepatol Commun, 1, pp.513~523 (2017)
47. Lee YS, "Retinoic acids and hepatic stellate cells in liver disease", J Gastroenterol Hepatol, 27(Suppl 2), pp.75~79 (2012)
48. Tsuchida T, "Mechanisms of hepatic stellate cell activation", Nat Rev Gastroenterol Hepatol, 14, pp.397~411 (2017)
49. He Z, "The roles and mechanisms of lncRNAs in liver fibrosis", Int J Mol Sci, 21, pp.1482~ (2020)
50. Zhang L, "Long noncoding RNA MEG3 induces cholestatic liver injury by interaction with PTBP1 to facilitate shp mRNA decay", Hepatology, 65, pp.604~615 (2017)
51. Yu F, "MALAT1 functions as a competing endogenous RNA to mediate Rac1 expression by sequestering miR-101b in liver fibrosis", Cell Cycle, 14, pp.3885~3896 (2015)
52. Jiang X, "The mechanism of lncRNA H19 in fibrosis and its potential as novel therapeutic target", Mech Ageing Dev, 188, pp.111243~ (2020)
53. Zhou B, "LncRNA Gm5091 alleviates alcoholic hepatic fibrosis by sponging miR-27b", 23b, Cell Biol Int, pp.2018, 42[DOI]
54. Goldstein J, "Novel and emerging therapies for cholestatic liver diseases", Liver Int, 38, pp.1520~1535 (2018)
55. Chiang JY, "Recent advances in understanding bile acid homeostasis", F1000Res, 6, pp.2029~ (2017)
56. Goodwin B, "A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis", Mol Cell, 6, pp.517~526 (2000)
57. Zhang Y, "Role of nuclear receptor SHP in metabolism and cancer", Biochim Biophys Acta, 1812, pp.893~908 (2011)
58. Denson LA, "The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp", Gastroenterology, 121, pp.140~147 (2001)
59. Zhang L, "H19 potentiates let-7 family expression through reducing PTBP1 binding to their precursors in cholestasis", Cell Death Dis, 10, pp.168~ (2019)
60. Gregory PA, "The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1", Nat Cell Biol, 10, pp.593~601 (2008)
61. Song Y, "H19 promotes cholestatic liver fibrosis by preventing ZEB1-mediated inhibition of epithelial cell adhesion molecule", Hepatology, 66, pp.1183~1196 (2017)
62. Li X, "The role of long noncoding RNA H19 in gender disparity of cholestatic liver injury in multidrug resistance 2 gene knockout mice", Hepatology, 66, pp.869~884 (2017)
63. Xiao Y, "Long Noncoding RNA H19 contributes to cholangiocyte proliferation and cholestatic liver fibrosis in biliary atresia", Hepatology, 70, pp.1658~1673 (2019)
64. Nagahashi M, "Conjugated bile acid-activated S1P receptor 2 is a key regulator of sphingosine kinase 2 and hepatic gene expression", Hepatology, 61, pp.1216~1226 (2015)
65. Liu R, "Conjugated bile acids promote cholangiocarcinoma cell invasive growth through activation of sphingosine 1-phosphate receptor 2", Hepatology, 60, pp.908~918 (2014)
66. Li X, "Cholangiocyte-Derived Exosomal lncRNA H19 Promotes Macrophage Activation and Hepatic Inflammation under Cholestatic Conditions", Cells, 9, pp.190~ (2020)

관련 논문AI추천